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ABSTRACT
Background: Early diagnosis and treatment of leukemia patients remains a fundamental aim in clinical
oncology, especially in developing country. Present study highlights the basic requirements of these patients
in Iran. Better understanding of these issues may lead to improve the healthcare standards toward leukemia
diagnosis and treatment.
Methods: 101This descriptive study included  specialists in hematology-oncology and pathology serving in
oncology centers. The participants were then asked to fill out a standard questionnaire on the issues around
diagnosis and treatment of blood malignancies.
Results: According to specialists, unfair distribution of facilities across the country, delayed diagnosis of
disease, absence of psychological support for patients, and insufficient financial support were the main
reasons of inappropriate diagnosis and treatment in leukemia patients.
Conclusions: Our results show that making an amendment to health policies by preparing well-equipped
medical centers in all provinces, improving the morale of patients through consultation during the process of
treatment, and above all, subsiding leukemia patients' financial problems will promote the health standard
regarding the leukemia diagnosis and treatment in Iran.
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INTRODUCTION
After cardiovascular diseases, cancers are the
second most common cause of mortality in
developed countries, and the third in
underdeveloped countries. The significance of
cancers as a major health problem has been
revealed by the increasing incidence over the world
by which the economic and psychological status of
families can be affected.1 Statistically, the rate of
cancers in Iran is increasing and it is much higher
than standard levels.2,3 According to the Iranian
Ministry of Health (2007), exclusively based on the
report of Pathology Center, cancers of skin, breast,
stomach, colorectal, liver, hematopoietic system,
esophagus, prostate, lung, brain, and the central
nervous system (CNS) are the most prevalent
